Skip to main content
Year archive

Bio Solution Co.,Ltd. — 2026 filings

All 16 regulatory filings released by Bio Solution Co.,Ltd. (086820) in 2026, sourced directly from the official regulator.

16 Filings
2026 Period
2026 filings (16)
Filing Released Lang
기업설명회(IR)개최
Regulatory Filings
2026-04-29 Korean
기업설명회(IR)개최
Investor Presentation
2026-04-17 Korean
기업설명회(IR)개최
Investor Presentation
2026-04-08 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-27 Korean
사업보고서 (2025.12)
Audit Report / Information FY 2025
2026-03-19 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-19 Korean
기업설명회(IR)개최
Investor Presentation
2026-03-18 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-12 Korean
주주총회집중일개최사유신고
Regulatory Filings
2026-03-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-12 Korean
전환청구권행사
Share Issue/Capital Change
2026-03-11 Korean
기업설명회(IR)개최
Investor Presentation
2026-02-24 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2026-02-12 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정) (펠렛형 동종 연골세포치료제(카티로이드)의 호주 제1/2상 임상시험계획 승인)
Legal Proceedings Report
2026-01-14 Korean